Abstract

Exocyclic DNA adducts are formed from metabolites of chemical carcinogens and have also been detected as endogenous lesions in human DNA. The exocyclic adduct 3,N4-etheno-2′-deoxycytidine (εdC), positioned opposite deoxyguanosine in the B-form duplex of the dodecanucleotide d(CGCGAATTεCGCG), has been crystallographically characterized at 1.8Å resolution. This self-complementary oligomer crystallizes in space group P3212, containing a single strand in the asymmetric unit. The crystal structure was solved by isomorphous replacement with the corresponding unmodified dodecamer structure. Exposure of both structures to identical crystal packing forces allows a detailed investigation of the influence of the exocyclic base adduct on the overall helical structure and local geometry. Structural changes are limited to the εC:G and adjacent T:A and G:C base-pairs. The standard Watson–Crick base-pairing scheme, retained in the T:A and G:C base-pairs, is blocked by the etheno bridge in the εC:G pair. In its place, a hydrogen bond involving O2 of εC and N1 of G is present. Comparison with an εdC-containing NMR structure confirms the general conformation reported for εC:G, including the hydrogen bonding features. Superposition with the crystal structure of a DNA duplex containing a T:G wobble pair shows similar structural changes imposed by both mismatches. Evaluation of the hydration shell of the duplex with bond valence calculations reveals two sodium ions in the crystal.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.